Evidence map›Paper›PMID 33415517›Full record

GuidelineHead and neck pathology2021

Proliferative Verrucous Leukoplakia: An Expert Consensus Guideline for Standardized Assessment and Reporting.

Lester D R Thompson, Sarah G Fitzpatrick, Susan Müller, Ellen Eisenberg, Jasbir D Upadhyaya, Mark W Lingen, Nadarajah Vigneswaran, Sook-Bin Woo, Indraneel Bhattacharyya, Elizabeth A Bilodeau and 11 more

Open access · greenAbstract readPractice GuidelineConsensus Statement
In one paragraph

Guideline in Head and neck pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. [Progress in clinicopathological diagnosis of oral potentially malignant disorders].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 2 countries.

Lester D R Thompson *Department of Pathology, Southern California Permanente Medical Group, Woodland Hills Medical Center, 5601 De Soto Avenue Woodland Hills, CA, 91364, Woodland Hills, USA. Lester.D.Thompson@KP.org.ORCID http://orcid.org/0000-0003-3714-1432
Sarah G Fitzpatrick *Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, USA.
Susan MüllerAtlanta Oral Pathology, Emory University School of Medicine, Decatur, GA, USA.
Ellen EisenbergOral Health and Diagnostic Sciences, University of Connecticut Health, Farmington, CT, USA.
Jasbir D UpadhyayaSection of Diagnostic Sciences, Department of Applied Dental Medicine, Southern Illinois University School of Dental Medicine, Alton, IL, USA.
Mark W LingenDepartment of Pathology, University of Chicago Medicine, Chicago, IL, USA.
Nadarajah VigneswaranDepartment of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry at Houston, Houston, TX, USA.
Sook-Bin WooDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.
Indraneel BhattacharyyaDepartment of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, USA.
Elizabeth A BilodeauDepartment of Diagnostic Sciences, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA, USA.
Roman CarlosCentro Clínico de Cabeza y Cuello, Patología División, Guatemala City, Guatemala.
Mohammed N IslamDepartment of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, USA.
Marino E LeonDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
James S LewisDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Kelly R MaglioccaDepartment of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Haresh ManiDepartment of Pathology, Inova Fairfax Hospital, Falls Church, VA, USA.
Mitra MehradDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Bibianna PurginaDepartment of Pathology, University of Ottawa, Ottawa, Ontario, Canada.
Mary RichardsonDepartment of Pathology, MUSC Health-University Medical Center, Charleston, SC, USA.
Bruce M WenigDepartment of Pathology, Moffitt Cancer Center, Tampa, FL, USA.
Donald M CohenDepartment of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, USA.
University of Florida · USEmory University · USVanderbilt University Medical Center · USHarvard University · USInova Fairfax Hospital · USMedical University of South Carolina · USMoffitt Cancer Center · USUConn Health · USUniversity of Chicago · USUniversity of Ottawa · CAUniversity of Pittsburgh · USWoodland Hills Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The many diverse terms used to describe the wide spectrum of changes seen in proliferative verrucous leukoplakia (PVL) have resulted in disparate clinical management. The objective of this study was to produce an expert consensus guideline for standardized assessment and reporting by pathologists diagnosing PVL related lesions. 299 biopsies from 84 PVL patients from six institutions were selected from patients who had multifocal oral leukoplakic lesions identified over several years (a minimum follow-up period of 36 months). The lesions demonstrated the spectrum of histologic features described in PVL, and in some cases, patients developed oral cavity squamous cell carcinoma (SCC). An expert working group of oral and maxillofacial and head and neck pathologists reviewed microscopic features in a rigorous fashion, in combination with review of clinical photographs when available. The working group then selected 43 single slide biopsy cases for whole slide digital imaging (WSI) review by members of the consensus conference. The digital images were then reviewed in two surveys separated by a washout period of at least 90 days. Five non-PVL histologic mimics were included as controls. Cases were re-evaluated during a consensus conference with 19 members reporting on the cases. The best inter-observer diagnostic agreement relative to PVL lesions were classified as "corrugated ortho(para)hyperkeratotic lesion, not reactive" and "SCC" (chi-square p = 0.015). There was less than moderate agreement (kappa < 0.60) for lesions in the "Bulky hyperkeratotic epithelial proliferation, not reactive" category. There was ≥ moderate agreement (> 0.41 kappa) for 35 of 48 cases. This expert consensus guideline has been developed with support and endorsement from the leadership of the American Academy of Oral and Maxillofacial Pathology and the North American Society of Head and Neck Pathologists to recommend the use of standardized histopathologic criteria and descriptive terminology to indicate three categories of lesions within PVL: (1) "corrugated ortho(para)hyperkeratotic lesion, not reactive;" (2) "bulky hyperkeratotic epithelial proliferation, not reactive;" and (3) "suspicious for," or "squamous cell carcinoma." Classification of PVL lesions based on a combination of clinical findings and these histologic descriptive categories is encouraged in order to standardize reporting, aid in future research and potentially guide clinical management.

Indexed as

HumansLeukoplakia, OralPathology, OralClassificationConsensusPathology criteriaProliferative verrucous leukoplakiaStandardized criteria

Identifiers

PMID33415517
PMCPMC8134585
OpenAlexW3119680478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.